Initiation of Medications for Opioid Use Disorder Shortly Before Release From Prison to Promote Treatment Retention: Strong Evidence but Compromised Policy.

Curtis, Michael; Larney, Sarah; Higgs, Peter; Cossar, Reece D; Winter, Rebecca J; Stewart, Ashleigh C; Stoové, Mark

Curtis, Michael; Larney, Sarah; Higgs, Peter; Cossar, Reece D; Winter, Rebecca J; Stewart, Ashleigh C; Stoové, Mark.

Afiliação

Larney S; Centre de Recherche du Centre Hospitalier de l'Université de Montréal, Montréal Quebec, Canada.
Higgs P; Department of Family Medicine and Emergency Medicine Université de Montréal Canada.
Cossar RD; National Drug and Alcohol Research Centre UNSW Sydney Sydney, NSW, Australia.
Winter RJ; Behaviours and Health Risks Program Public Health Discipline Burnet Institute Melbourne, VIC, Australia.
Stewart AC; Department of Public Health LaTrobe University Victoria, Australia.
Stoové M; Behaviours and Health Risks Program Public Health Discipline Burnet Institute Melbourne, VIC, Australia.

J Addict Med ; 15(6): 525-526, 2021.

Article em En | MEDLINE | ID: mdl-33298751

Assuntos

Transtornos Relacionados ao Uso de Opioides; Prisões; Humanos; Tratamento de Substituição de Opiáceos; Transtornos Relacionados ao Uso de Opioides/tratamento farmacológico; Políticas

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Prisões / Transtornos Relacionados ao Uso de Opioides Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google